| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
| Leishmaniasis | D007896 | 19 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| Urethritis | D014526 | 9 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Johnson EM et al. | Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations. | 1998 | Antimicrob. Agents Chemother. | pmid:9624486 |
| Alonso MA et al. | Compounds affecting membranes that inhibit protein synthesis in yeast. | 1979 | Antimicrob. Agents Chemother. | pmid:394675 |
| te Welscher YM et al. | Natamycin inhibits vacuole fusion at the priming phase via a specific interaction with ergosterol. | 2010 | Antimicrob. Agents Chemother. | pmid:20385867 |
| Gunderson SM et al. | In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect. | 2000 | Antimicrob. Agents Chemother. | pmid:10991881 |
| Boyce ST et al. | Noncytotoxic combinations of topical antimicrobial agents for use with cultured skin substitutes. | 1995 | Antimicrob. Agents Chemother. | pmid:7574524 |
| Venables P and Russell AD | Nystatin-induced changes in Saccharomyces cerevisiae. | 1975 | Antimicrob. Agents Chemother. | pmid:1094947 |
| Randhawa P et al. | BK Virus replication in vitro: limited effect of drugs interfering with viral uptake and intracellular transport. | 2007 | Antimicrob. Agents Chemother. | pmid:17893158 |
| Serfling A et al. | Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy. | 2007 | Antimicrob. Agents Chemother. | pmid:17620378 |
| Offner F et al. | Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B. | 2004 | Antimicrob. Agents Chemother. | pmid:15561860 |
| Razonable RR et al. | Nystatin induces secretion of interleukin (IL)-1beta, IL-8, and tumor necrosis factor alpha by a toll-like receptor-dependent mechanism. | 2005 | Antimicrob. Agents Chemother. | pmid:16048981 |